- Home
- ALVOW vs RILYP Comparison
ALVOW vs RILYP Comparison
Compare ALVOW & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVOW
- RILYP
- Stock Information
- Founded
- ALVOW 2013
- RILYP 1973
- Country
- ALVOW Luxembourg
- RILYP United States
- Employees
- ALVOW 999
- RILYP N/A
- Industry
- ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
- RILYP Investment Managers
- Sector
- ALVOW Health Care
- RILYP Finance
- Exchange
- ALVOW Nasdaq
- RILYP Nasdaq
- Market Cap
- ALVOW N/A
- RILYP N/A
- IPO Year
- ALVOW N/A
- RILYP N/A
- Fundamental
- Price
- ALVOW $1.55
- RILYP $4.00
- Analyst Decision
- ALVOW
- RILYP
- Analyst Count
- ALVOW 0
- RILYP 0
- Target Price
- ALVOW N/A
- RILYP N/A
- AVG Volume (30 Days)
- ALVOW 15.0K
- RILYP 20.1K
- Earning Date
- ALVOW 02-27-2025
- RILYP 01-01-0001
- Dividend Yield
- ALVOW N/A
- RILYP 32.23%
- EPS Growth
- ALVOW N/A
- RILYP N/A
- EPS
- ALVOW N/A
- RILYP N/A
- Revenue
- ALVOW $393,919,000.00
- RILYP $854,383,000.00
- Revenue This Year
- ALVOW N/A
- RILYP N/A
- Revenue Next Year
- ALVOW N/A
- RILYP N/A
- P/E Ratio
- ALVOW N/A
- RILYP N/A
- Revenue Growth
- ALVOW 517.92
- RILYP N/A
- 52 Week Low
- ALVOW $2.33
- RILYP $3.28
- 52 Week High
- ALVOW $2.33
- RILYP $20.49
- Technical
- Relative Strength Index (RSI)
- ALVOW N/A
- RILYP 45.87
- Support Level
- ALVOW N/A
- RILYP $4.66
- Resistance Level
- ALVOW N/A
- RILYP $5.43
- Average True Range (ATR)
- ALVOW 0.00
- RILYP 0.79
- MACD
- ALVOW 0.00
- RILYP 0.03
- Stochastic Oscillator
- ALVOW 0.00
- RILYP 39.18
About ALVOW Alvotech Warrant
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.